Quick Answer
Invivyd, Inc. reported R&D Expense of $38.31 million for fiscal year 2025.
Invivyd, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $38.31M | -72.1% |
| 2024 | $137.25M | -13.5% |
| 2023 | $158.66M | -11.5% |
| 2022 | $179.21M | -2.0% |
| 2021 | $182.89M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.05M | -86.1% | -16.0% |
| June 30, 2025 | $9.57M | -68.4% | -10.0% |
| March 31, 2025 | $10.64M | -65.9% | -81.6% |
| September 30, 2024 | $57.85M | +126.2% | +90.7% |
| June 30, 2024 | $30.33M | -30.5% | -2.7% |
| March 31, 2024 | $31.16M | +14.6% | +21.8% |
| September 30, 2023 | $25.57M | -15.1% | -41.4% |
| June 30, 2023 | $43.62M | +17.5% | +60.4% |
- Invivyd, Inc. showed a decrease of -72.1% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, Invivyd, Inc.’s r&d expense has declined by 79.1% (from $182.89 million to $38.31 million).
- The most recent figure is from Invivyd, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: